132 related articles for article (PubMed ID: 11108721)
21. Molecular cloning of Elk-3, a new member of the Ets family expressed during mouse embryogenesis and analysis of its transcriptional repression activity.
Nozaki M; Onishi Y; Kanno N; Ono Y; Fujimura Y
DNA Cell Biol; 1996 Oct; 15(10):855-62. PubMed ID: 8892757
[TBL] [Abstract][Full Text] [Related]
22. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway.
Nguyen MH; Ho JM; Beattie BK; Barber DL
J Biol Chem; 2001 Aug; 276(35):32704-13. PubMed ID: 11435425
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of the ets-related human transcription factor ER81.
Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
[TBL] [Abstract][Full Text] [Related]
24. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.
Salomon-Nguyen F; Della-Valle V; Mauchauffe M; Busson-Le Coniat M; Ghysdael J; Berger R; Bernard OA
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6757-62. PubMed ID: 10829078
[TBL] [Abstract][Full Text] [Related]
25. DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association.
Green SM; Coyne HJ; McIntosh LP; Graves BJ
J Biol Chem; 2010 Jun; 285(24):18496-504. PubMed ID: 20400516
[TBL] [Abstract][Full Text] [Related]
26. Proteins of the ETS family with transcriptional repressor activity.
Mavrothalassitis G; Ghysdael J
Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
[TBL] [Abstract][Full Text] [Related]
27. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
28. Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene.
Cho JY; Akbarali Y; Zerbini LF; Gu X; Boltax J; Wang Y; Oettgen P; Zhang DE; Libermann TA
J Biol Chem; 2004 May; 279(19):19512-22. PubMed ID: 14970218
[TBL] [Abstract][Full Text] [Related]
29. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9.
Chakrabarti SR; Sood R; Ganguly S; Bohlander S; Shen Z; Nucifora G
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7467-72. PubMed ID: 10377438
[TBL] [Abstract][Full Text] [Related]
30. TEL gene rearrangements in myeloid malignancy.
Golub TR
Hematol Oncol Clin North Am; 1997 Dec; 11(6):1207-20. PubMed ID: 9443053
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H
Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377
[TBL] [Abstract][Full Text] [Related]
32. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
[TBL] [Abstract][Full Text] [Related]
33. Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene.
Rho JK; Kim JH; Yu J; Choe SY
Biochem Biophys Res Commun; 2002 Sep; 297(1):91-5. PubMed ID: 12220513
[TBL] [Abstract][Full Text] [Related]
34. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
[TBL] [Abstract][Full Text] [Related]
35. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies.
Chakrabarti SR; Sood R; Nandi S; Nucifora G
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13281-5. PubMed ID: 11078523
[TBL] [Abstract][Full Text] [Related]
36. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression.
Kim CA; Phillips ML; Kim W; Gingery M; Tran HH; Robinson MA; Faham S; Bowie JU
EMBO J; 2001 Aug; 20(15):4173-82. PubMed ID: 11483520
[TBL] [Abstract][Full Text] [Related]
37. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
38. v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6).
Lopez RG; Carron C; Ghysdael J
J Biol Chem; 2003 Oct; 278(42):41316-25. PubMed ID: 12893822
[TBL] [Abstract][Full Text] [Related]
39. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
[TBL] [Abstract][Full Text] [Related]
40. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
